Innovis Asset Management’s AbbVie ABBV Stock Holding History

Innovis Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$1.45M	Sell	9,706 -2,087	-18%	-$306K	0.56%	36
2023 Q2	$1.59M	Sell	11,793 -97	-0.8%	-$14.2K	0.59%	38
2023 Q1	$1.89M	Sell	11,890 -1,169	-9%	-$179K	0.77%	38
2022 Q4	$2.11M	Buy	+13,059	New	+$2M	0.95%	31

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Innovis Asset Management's ABBV Position: Q3 2023 in Review

Innovis Asset Management reduced its AbbVie (ABBV) stake by 18% in Q3 2023, selling an estimated $306K and leaving 9,706 shares worth $1.45M. The position accounts for 0.56% of the portfolio, ranked #36.

Innovis Asset Management first reported a position in ABBV in Q4 2022 and has held it in 4 quarters since. The position peaked at $2.11M in Q4 2022. 3,112 funds tracked by Wall St. Rank hold ABBV as of Q3 2023.

Innovis Asset Management held 9,706 shares of AbbVie worth $1.45M as of Q3 2023.
Innovis Asset Management sold 2,087 AbbVie shares in Q3 2023, an estimated $306K.
AbbVie made up 0.56% of Innovis Asset Management's portfolio in Q3 2023, its #36 holding.
Innovis Asset Management first reported a position in AbbVie in Q4 2022 and has held it in 4 quarters since.
Innovis Asset Management's AbbVie position peaked at $2.11M in Q4 2022.
3,112 funds tracked by Wall St. Rank held AbbVie as of Q3 2023.

Based on Innovis Asset Management's 13F filing for Q3 2023, filed 9 Nov 2023.